Qingqing Yang
NO.168, Changhai Road
Shanghai, 200433, China
Shanghai, 200433, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Discovery of a Novel Potent and Orally Efficacious PGK1 Inhibitor C67-47 for the Treatment of Human Pancreatic Cancer.
Journal: Journal of medicinal chemistry
Published: May 29, 2026
ELANE enhances KEAP1 protein stability and reduces NRF2-mediated ferroptosis inhibition in metabolic dysfunction-associated fatty liver disease.
Journal: Cell death & disease
Published: November 09, 2024
Longikaurin A induces ferroptosis and inhibits glioblastoma progression through DNA methylation - Mediated GPX4 suppression.
Journal: European journal of pharmacology
Published: July 28, 2024
Lactate binds and inhibits the innate immune sensor STING to promote tumor immune evasion.
Journal: Immunity
Published: June 20, 2024
NLRP12 c.1382dup promotes the development of Crohn's disease through the ERK/NLRP3/ IL-1β pathway.
Journal: Gene
Published: June 14, 2024
Functional Connectivity-Based Searchlight Multivariate Pattern Analysis for Discriminating Schizophrenia Patients and Predicting Clinical Variables.
Journal: Schizophrenia bulletin
Published: May 31, 2024
OXCT1 succinylation and activation by SUCLA2 promotes ketolysis and liver tumor growth.
Journal: Molecular cell
Published: May 23, 2024
Intracellular C5aR1 inhibits ferroptosis in glioblastoma through METTL3-dependent m6A methylation of GPX4.
Journal: Cell death & disease
Published: January 15, 2024
RPLP2 activates TLR4 in an autocrine manner and promotes HIF-1α-induced metabolic reprogramming in hepatocellular carcinoma.
Journal: Cell death discovery
Published: July 29, 2023
NAT10-mediated AXL mRNA N4-acetylcytidine modification promotes pancreatic carcinoma progression.
Journal: Experimental cell research
Published: November 10, 2022
Last Updated: 09/26/2026